Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.21 (-4.37%)
As of: Oct 2, 2026 · 3:57 PM EDT

Niki BioSolutions (NIKI) Accumulated Depreciation (2022 - 2025)

Updated

Niki BioSolutions (NIKI) recorded Accumulated Depreciation of $85,315 in Q4 2025, up 32.3% from $64,487 a year earlier.

Analysis

Niki BioSolutions (NIKI) Accumulated Depreciation (2022 - 2025) Analysis & Trends

  • Annual Accumulated Depreciation has a three-year compound annual growth rate of -73.5% (FY2022 to FY2025).
  • Across earlier years, Accumulated Depreciation came in at $4.78 million in FY2024 (+29.8%), $3.69 million in FY2023 (-19.3%) and $4.57 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Niki BioSolutions 2.67 Mn 2.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2025 85,315.00
May 31, 2024 64,487.00
Dec 31, 2023 3.69 Mn
Dec 31, 2022 4.57 Mn
API Access

Niki BioSolutions Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=NIKI&period=max&api_key=YOUR_API_KEY